Regardless of how you feel about any given government shutdown, they do provide a great opportunity to evaluate what the government is actually doing when agencies are funded. A strong argument can be made that President Trump and his supporters should be eager to reopen the government so that the administration can continue its unprecedented work in cutting regulatory red tape.

However, this is not so much the case when it comes to the Food and Drug Administration. Some of the current agenda items at the FDA should leave supporters of the Trump administration scratching their heads.